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 ABSTRACT 
To investigate the effects of respiration defects on the disease phenotypes, we generated 
trans-mitochondrial mice (mito-mice) by introducing a mutated G13997A mtDNA, 
which specifically induces respiratory complex I defects and metastatic potentials in 
mouse tumor cells. First, we obtained ES cells and chimeric mice containing the 
G13997A mtDNA, and then we generated mito-mice carrying the G13997A mtDNA 
via its female germ line transmission. The three-month-old mito-mice showed complex 
I defects and lactate overproduction, but showed no other phenotypes related to 
mitochondrial diseases or tumor formation, suggesting that aging or additional nuclear 
abnormalities are required for expression of other phenotypes.  
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1. Introduction 
 Pathogenic mtDNA mutations that induce significant respiration defects are 
responsible for expression of mitochondrial diseases [1-3]. Moreover, such respiration 
defects and the resultant over production of reactive oxygen species (ROS) and lactate 
could also be involved in aging, age-associated disorders, and tumor development [2-5]. 
However, because of the control of the mitochondrial respiratory function by both 
nuclear DNA and mtDNA [1, 2], it has been difficult to determine which genome, 
nuclear DNA or mtDNA, is responsible for the respiration defects and the resultant 
abnormalities.  
 Our previous study [6] resolved this issue by using complete mtDNA exchange 
technology between two mouse lung carcinoma cell lines, P29 and A11, which express 
different metastatic phenotypes. The results showed that the highly metastatic A11 cells 
possess a somatic mtDNA mutation G13997A in the ND6 gene that encodes NADH 
dehydrogenase subunit 6, one of the subunits of respiration complex I, and that the 
mutation reversibly controls development of metastases in tumor cells. Moreover, the 
induction of metastasis in the tumor cells was due to the complex I defects-mediated 
overproduction of ROS, but not to the complex I defects-mediated overproduction of 
lactate [7]. In humans, complex I defects caused by pathogenic mtDNA mutations are 
also thought to be responsible for expression of Leber’s hereditary optic neuropathy 
(LHON), one of the most frequent mitochondrial diseases [1-3].  
 Therefore, generation of trans-mitochondrial mito-mice possessing the 
G13997A mtDNA introduced from highly metastatic tumor cells would provide an ideal 
system to examine whether somatic mtDNA mutations introduced from highly 
metastatic tumor cells into ES cells can be transmitted to the following generations, and 
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whether they can induce complex I defects in living mouse tissues and induce 
phenotypes related to LHON, aging, and metastasis. Here, we generated the trans-
mitochondrial mito-mice with homoplasmic G13997A mtDNA in all the tissues using 
mtDNA transfer technology, and then examined the resultant phenotypes. 
 
2. Materials and Methods 
2.1. Cell lines and cell culture 
Mouse tumor cells were grown in RPMI 1640 (Nissui Seiyaku, Tokyo, Japan) 
containing 10% fetal calf serum, uridine (50 ng/ml), and pyruvate (0.1 μg/ml). Mouse 
ES cells (TT2-F, an XO subline established from XY TT2 cells [8]) and mtDNA-
repopulated ES cells were cultivated on mitomycin C-inactivated feeder cells derived 
from fetal fibroblasts, in Dulbecco's Modified Eagle Medium (DMEM; Invitrogen, 
Carlsbad, CA, USA) supplemented with 15% KNOCKOUTTM Serum Replacement 
(Invitrogen), 1× non-essential amino acids (MP Biomedicals LLC, OH, USA), leukemia 
inhibitory factor (105 units/ml, Invitrogen), and 100 μM 2-mercaptoethanol (Sigma-
Aldrich, St. Louis, MO, USA). 
2.2. Isolation of ESmt13997 cells carrying the imported G13997A mtDNA 
The host ES cells were pretreated with rhodamine 6G (R6G; 0.38 to 1.5 μg/ml in 
3% ethanol) for 48 h in medium supplemented with uridine (50 ng/ml) and pyruvate 
(0.1 μg/ml) to eliminate endogenous mitochondria and mtDNA [9, 10]. The ES cells 
were then washed with phosphate-buffered saline (PBS) and suspended in R6G-free 
medium for 2 h to allow recover. The mtDNA donor B82mtA11 cells pretreated with 
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cytochalasin B (10 μg/ml) for 10 min were centrifuged at 15000g for 30 min at 37°C for 
enucleation. The resultant cytoplasts were fused with R6G-pretreated ES cells using 
polyethylene glycol, and the fusion mixture was cultivated in selective medium with 
HAT (hypoxanthine aminopterin thymidine). Seven days after fusion, growing colonies 
were picked up for further examination. 
2.3. Generation of founder chimeric mice and mito-mice13997 
After frozen 8-cell-stage embryos of ICR strain mice (ARK Resource Co., Ltd., 
Kumamoto, Japan) were thawed, their zona pellucidae were removed by treatment with 
acidified Tyrode’s buffer (Sigma-Aldrich). Each treated embryo was placed with 10 
ESmt13997 cells in an indentation well of a 35-mm culture dish and cultured overnight 
to enable aggregation. The next day, the embryos were transferred into pseudopregnant 
ICR females (Japan SLC). The resultant progeny were identified by their coat-color 
chimerism. Founder (F0) chimeric females were mated with C57BL/6J (B6; CLEA 
Japan) males to produce the F1 generation, and the F1 female mice were backcrossed 
with B6 males. The F3 generation was used for further analyses.  
2.4. Genotyping of mtDNAs 
To detect the presence of the G13997A mutation, a 147-bp fragment containing 
the 13997 site was amplified by PCR. The nucleotide sequences from nucleotide 
position 13963 to 13996 (5′-CCCACTAACAATTAAACCTAAACCTCCATActTA-3′, 
small letters indicate the mismatch site) and nucleotide position 14109 to 14076 (5′-
TTCATGTCATTGGTCGCAGTTGAATGCTGTGTAG-3′) were used as  
oligonucleotide primers. Combination of the PCR-generated mutation with the 
G13997A mutation creates a restriction site for Afl II, and generates 114-bp and 33-bp 
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fragments on Afl II digestion. The restriction fragments were separated by 
electrophoresis in a 3% agarose gel. For quantification of the G13997A mtDNA, we 
used the NIH IMAGE program. 
2.5. Analysis of multipotency of mtDNA-repopulated ES cells 
To test the multipotency of the mtDNA-repopulated ES cells, ES cells and  
ESmt13997 cells, 1 × 106 cells of each, were inoculated subcutaneously into the backs 
of 6-week-old nude mice (JCL, BALB/c-nu/nu; CLEA Japan). The resulting teratomas 
(tumors) were fixed in 30% neutral-buffered formalin, embedded in paraffin, stained 
with hematoxylin and eosin (HE) and examined histologically. 
2.6. Biochemical measurement of respiratory enzyme activities 
Mitochondrial respiratory complex I (NADH dehydrogenase), complex II 
(succinate dehydrogenase), complex III (cytochrome c reductase), and complex IV 
(cytochrome c oxidase) are components of the electron-transport chain, and are located 
in the mitochondrial inner membrane. The activity of these enzymes was assayed as 
described previously [11]. Briefly, for the estimation of complex I + III activity, NADH 
and cytochrome c (oxidized form) were used as substrates and the reduction of 
cytochrome c was monitored by measuring absorbance at 550 nm. For the estimation of 
complexes II + III activity, sodium succinate and cytochrome c (oxidized form) were 
used as substrates, and the reduction of cytochrome c was monitored as described above. 
For the estimation of complex IV activity, cytochrome c (reduced form) was used as a  
substrate, and the oxidation of cytochrome c was measured at 550 nm. 
2.7. Lactate measurement 
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To determine fasting blood lactate concentrations, blood was collected from the 
tail veins of mice after overnight starvation. After oral administration of glucose (1.5 
g/kg body weight), blood was again collected, and lactate concentrations were measured 
using an automatic blood lactate test meter (Lactate Pro, ARKRAY, Kyoto, Japan). 
2.8. Measurement of ROS production 
ROS generation was detected with 2′,7′-dichlorofluorescin diacetate (DCFH-
DA; Molecular Probe, Inc., Eugene, OR, USA). Cells were incubated with DCFH-DA, 
washed twice, and then immediately analyzed by using a FACScan flow cytometer 
(Becton Dickinson, Mountain View, CA, USA).  
2.9. Western blot analysis of ROS scavenger enzymes 
Tissue samples were lysed on ice in 2% SDS (Wako, Osaka, Japan), 50 mM Tris–HCl 
(pH 6.8), 10% Glycerol (Wako), 5% 2-Mercaptoethanol (Wako) and 0.02% 
Bromophenol Blue (Wako). After centrifugation at 45,000 rpm for 30 min at 4 °C, the 
supernatant was used as a protein sample. For Western blot analysis of manganese 
superoxide dismutase (MnSOD), glutathione peroxidase (GPx), and catalase, the 
proteins were resolved by SDS-PAGE under reducing conditions. The resolved proteins 
were transferred electrophoretically to a nitrocellulose membrane (GE Healthcare Bio-
Science KK, Tokyo, Japan). The membrane was incubated with either anti-MnSOD 
antibody (Upstate Biotechnology, Lake Placid, NY, USA), anti-Glutathione Peroxidase 
1 antibody (Abcam, Cambridge, UK), or anti-Catalase antibody (Calbiochem, 
Darmstadt, Germany) for 2 h. Proteins were detected using Immunostaining HRP-1000 
(Konica Minolta, Tokyo, Japan). An anti-β-actin antibody (Sigma-Aldrich) was used for 
the loading control. 
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2.10. Histological analysis of eyes 
Eyes with attached optic nerves were fixed in 30% neutral-buffered formalin and 
embedded in paraffin. Cross-sections of the optic nerve and horizontal sections of the 
retina were stained with HE for light microscopic examination.  
 
3. Results 
3.1. Isolation of trans-mitochondrial ES cells carrying G13997A mtDNA 
 To obtain trans-mitochondrial ES cells carrying the G13997A mtDNA 
(ESmt13997 cells), we used mouse ES cells and mouse B82mtA11 cells as the 
recipients and the donors of the G13997A mtDNA, respectively (Supplementary Table 
1). The B82mtA11 cells were isolated previously [6] by fusing enuclated A11 cells with 
mtDNA-less B82 cells. Since the B82mtA11 cells could not survive in the selection 
medium with HAT, they could be used as mtDNA donors for mouse ES cells 
(Supplementary Table 1). 
 ES cells were pretreated with R6G to eliminate endogenous mitochondria and 
mtDNA, and then fused with enucleated B82mtA11 cells. Unfused R6G-pretreated ES 
cells failed to grow due to the absence of mitochondria and mtDNA, and unenucleated 
B82mtA11 cells failed to grow by the HAT selection (Supplementary Table 1).  
 Growing colonies in the selection medium were clonally isolated, and seven 
clones were used for mtDNA genotyping. All seven clones possessed various 
proportions of the imported G13997A mtDNA (Fig. 1A). The mtDNA without the 
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mutation in these clones would be derived from feeder cells or ES cells carrying their 
own mtDNA due to incomplete R6G pre-treatment. We selected two clones, 
ESmt13997-5 and -7, which possessed 55% and 85% G13997A mtDNA, respectively, 
as ESmt13997 cells for use in further experiments. 
 
3.2. Effects of the imported G13997A mtDNA on differentiation of the ESmt13997 cells 
 In previous reports [12-14], chimeric mice were not obtained from trans-
mitochondrial ES cells carrying the pathogenic mtDNAs that induce significant 
respiration defects, suggesting that significant respiration defects inhibited the 
differentiation of multipotent ES cells. Therefore, we tested whether the ESmt13997 
cells are able to differentiate into various tissues, by subcutaneously inoculating 
ESmt13997-7 cells into the back skin of nude mice. They formed primary tumors, 
which grew faster than those of the ES cells with wild-type mtDNA (Supplementary Fig. 
1A). Faster growth of the inoculated ESmt13997 cells would be due to the induction of 
hypoxia-resistant phenotypes in the cells with the G13997A mtDNA [6]. 
 Histological analysis of the primary tumors showed that both the ESmt13997-7 
cells and the ES cells with wild-type mtDNA were capable of differentiation into 
multiple tissue types, such as secretory cells, bone cells, striated muscle, and hair 
follicles (Supplementary Fig. 1B), even though ESmt13997-7 cells showed faster 
growth as primary tumors (Supplementary Fig. 1A). These observations suggested that 
the ESmt13997 cells could be used to obtain F0 chimeric mice. 
 
 7
  
3.3. Generation of mito-mice13997 carrying homoplasmic G13997A mtDNA 
To generate F0 chimeric mice, ESmt13997-5 and -7 cells were aggregated with 
8-cell-stage embryos of ICR strain mice. We obtained 24 F0 chimeric mice (11 females 
and 13 males) showing 5% to 90% chimerism by coat color (Table 1). The results of 
mtDNA genotyping showed that 5 of 13 F0 males and 6 of 11 F0 females possessed 1% 
to 43% G13997A mtDNA in their tails (Table 1). Because mouse mtDNA inherits 
strictly maternally [15, 16], we used all 11 F0 females as founders, irrespective of 
whether their tails possessed the G13997A mtDNA or not, and mated them with B6 
males for examination of its female germ line transmission to the F1 progeny.  
 Of the 11 F0 females, only one produced F1 pups (2 females and 5 males) that 
possessed homoplasmic G13997A mtDNA in their tails (Table 1). This F0 female was 
derived from the ES mt13997-5 clone carrying 55% G13997A mtDNA. Probably, the 
ESmt13997-5 possessed homoplasmic G13997A mtDNA, and estimation of 55% 
G13997A mtDNA in the clone sample (Fig. 1A) was due to the presence of feeder cells. 
 Then, we examined one of the F1 males with homoplasmic G13997A mtDNA in 
its tail, and showed that all tissues tested possessed homoplasmic G13997A mtDNA 
(Fig. 1B). This finding suggests that the G13997A mtDNA transmitted maternally from 
an F0 female to F1 progeny, and that the F1 mice carry the G13997A mtDNA originally 
derived from highly metastatic Lewis lung carcinoma A11 cells. Mice carrying the 
homoplasmic G13997A mtDNA in all tissues were named mito-mice13997. 
 Our previous reports [12, 17] showed that mito-mice generated by introduction 
of the mtDNA with a large-scale deletion (ΔmtDNA) into fertilized eggs did not possess 
homoplasmic ΔmtDNA, because the ΔmtDNA induced embryonic lethality. Thus, 
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generation of the F1 mice carrying homoplasmic G13997A mtDNA (Fig. 1B) indicates 
that the pathogenicity of the G13997A mtDNA was not sufficient to induce embryonic 
lethality. 
 We mated two F1 female mito-mice13997 with B6 males and obtained F2 
progeny. Then, we obtained F3 progeny from seven F2 females. Three-month-old male 
mito-mice13997 of the F3 generation were used for further examination of respiratory 
function and disease phenotypes, while female mito-mice13997 were used to breed and 
maintain the mito-mice13997 line. Genotyping of mtDNA in one of the F3 males 
confirmed homoplasmic G13997A mtDNA in all the tissues tested (Fig. 1C). 
 
3.4. Mitochondrial dysfunction and disease phenotypes in the mito-mice13997 
 Using the mito-mice13997 (three-month-old F3 males), first we analyzed 
respiratory complex activities in various tissues. Tissues from age-matched B6 mice 
were used as normal controls. The activity levels of complexes II + III and complex IV 
in the tissues of mito-mice13997 were not significantly different to normal levels (Fig. 
2A). In contrast, all mito-mice13997 tissues tested showed significantly less complex I 
+ III activity (about 70% normal level). Since the activity of complexes II + III was 
normal in the mito-mice13997 tissues, we consider that the reduced activity of 
complexes I + III reflects complex I activity alone. 
 Our previous study [6] showed that complex I defects caused by the G13997A 
mtDNA induced simultaneous overproduction of ROS and lactate in cultivated tumor 
cells. So, we estimated the amounts of ROS in the liver cells and splenocytes of the 
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mito-mice13997 by means of fluorescence-activated cell sorting (FACS; Fig. 2B). The 
results showed no significant increase in the amount of ROS in the mito-mice13997 
tissues compared to the control B6 mice. Moreover, the levels of antioxidant enzymes, 
such as MnSOD, GPx, and catalase in the liver cells and splenocytes of the mito-
mice13997 were not significantly different to those in the control B6 mice (Fig. 2C). 
Thus, the tissues in living mice may have some systems other than the enhanced 
expression of anti-oxidant enzymes that suppress the ROS overproduction caused by the 
mutated mtDNA.  
 In contrast, after glucose loading, the lactate level in blood was significantly 
higher in mito-mice13997 than in control B6 mice (Fig. 3A). This phenotype is also 
found in other mito-mice [13, 17]. Moreover, in human cases, lactic acidosis is one of 
the most common phenotypes in the patients with mitochondrial diseases [1-3], and our 
results suggest that the mito-mice13997 can be used as models of lactic acidosis. 
 In humans, complex I defects caused by mtDNA mutations are also associated 
with LHON [1-3]. The typical clinical features of LHON are loss of central vision and 
optic nerve atrophy in young males due to the selective loss of retinal ganglion cells, 
which histologically correspond to the loss of the optic nerve and the loss of both the 
nerve fiber layer and ganglion cell layer in the retina [18]. So, we histologically 
examined the retinal ganglion cells in three-month-old male mito-mice13997. The 
results showed normal optic nerve in the size and nerve fiber density (Fig. 3B upper 
panels), and normal histology in both the nerve fiber layer and ganglion cell layer in the 
retina (Fig. 3B lower panels). These histological observations indicated that the male 
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mito-mice13997 did not express the typical phenotypes of LHON [18] at least 3 months 
after birth. 
 Finally we examined the tendency to form tumors using three-month-old mito-
mice13997 of F3 generation, since their G13997A mtDNA was derived from highly 
metastatic Lewis lung carcinoma A11 cells, and they showed high lactate levels in the 
blood (Fig. 3A). However, all six mito-mice13997 tested showed no bias towards the 
preferential formation of tumors. These results can be explained by the fact that the 
G13997A mtDNA induces metastasis in tumor cells, but does not induce tumor 
development in normal cells [6].  
 
4. Discussion 
Because mouse G13997A mtDNA in highly metastatic tumor cells induces 
respiratory complex I defects and leads to overproduction of ROS and lactates [6, 7], we 
expected that the generation of the mito-mice13997 with homoplasmic G13997A 
mtDNA would be an effective means to examine the conventional mitochondrial 
theories [2-5] proposing that ROS and lactate overproduction caused by pathogenic 
mtDNA mutations is responsible for aging, age-associated disorders, and tumor 
development.  
 As expected, the mito-mice13997 showed complex I defects (Fig. 2A) and 
resultant overproduction of lactate (Fig. 3A). However, the deficiency in complex I 
activity was less in mito-mice13997 tissues than in the mtDNA donor B82mtA11 cells 
(Fig. 2A). A similar compensatory effect was observed, when mito-mice6589 tissues 
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expressing complex IV defects due to homoplasmic T6589C mtDNA mutation in the 
COI gene were compared to their mtDNA donor cells [13]. Thus, the tissues in living 
mice may have some activities that compensate for the reduced respiration defects 
caused by pathogenic mtDNA mutations. 
 In addition, ROS overproduction, LHON phenotypes, and tumor formation were 
not observed in the mito-mice13997. Probably, the tissues in living mice are capable not 
only of compensating for reduced complex I activity, but also of suppressing ROS 
overproduction. In this study we used young mito-mice13997 to examine these 
phenotypes. Thus, we cannot at present exclude the possibility that aging of mito-
mice13997 abolishes the compensatory function in the young tissues, resulting in 
expression of these phenotypes in aged mito-mice13997.  
 With respect to the LHON phenotypes, it has been proposed that a mutation in 
either the ND1, ND4, or ND6 gene of mtDNA is necessary, but not sufficient to express 
LHON phenotypes, and that some additional nuclear gene mutations are required [1-3]. 
Hence, addition of similar nuclear gene mutations may induce the LHON phenotypes in 
the mito-mice13997. The absence of tumor formation in the mito-mice13997 suggests 
that increased lactate levels in the presence of oxygen, which is known as the Warburg 
effect [19], were not sufficient to induce tumor formation in the mito-mice13997. Since 
our previous report [6] showed that the G13997A mtDNA induces metastasis in tumor 
cells, but does not induce tumor formation in normal cells, it can be expected that the 
mito-mice13997 would not show tumor formation, but would show high metastasis, 
only when nuclear gene mutations or a different nuclear background that preferentially 
induce tumor formation were introduced. 
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 Therefore, aging of the mito-mice13997 and/or the introduction of different 
nuclear backgrounds or nuclear gene abnormalities into the mito-mice13997 would be 
important for further investigation of the capability of the mito-mice13997 to express 
significant complex I defects, ROS overproduction, tumor formation, metastasis, and 
the phenotypes related to LHON and aging.  
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7. Figure legends 
Fig. 1. The mtDNA genotyping of ESmt13997 and mito-mice13997. 
Genotyping of mtDNA from (A) ESmt13997 clones, (B) F1 male tissues, and (C) F3 
male tissues. PCR products were digested with Afl II. The G13997A mtDNA produced 
114- and 33-bp fragments due to the gain of an Afl II site by the G13997A substitution 
in the ND6 gene, whereas wild-type mtDNA without the mutation produced a 147-bp 
fragment. B82mtA11 cells with homoplasmic G13997A mtDNA were used as positive 
controls, and ES cells and B82mtB6 cells with wild-type mtDNA were used as negative 
controls. Br, brain; He, heart; Li, liver; Ki, kidney; Sk, skeletal muscle; Te, testis. 
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Fig. 2. Phenotypes related to mitochondrial respiratory function. 
Open bars, samples with wild-type mtDNA; solid bars, samples with the G13997A 
mtDNA. Mit represents mito-mice13997. B82mtA11 cells with the G13997A mtDNA 
and B82mtB6 cells with wild-type mtDNA shared the same nuclear background, and 
were used to compare relative complex I activity and the amounts of ROS between 
cultivated cells with and without the G13997A mutation. (A) Biochemical analysis of 
respiratory complex activities. Respiratory complex I+III, II+III, and IV activities were 
examined using tissues of the mito-mice13997. Data are presented as mean values with 
SD (n=3), *P < 0.05 compared with control group. (B) Flow-cytometric analysis of 
ROS production. We treated B82mtA11 cells, B82mtB6 cells, liver cells and 
splenocytes with DCFH-DA, and carried out flow-cytmetric analysis for quantitative 
estimation of H2O2. Liver cells were obtained from homogenized tissue in a buffer 
containing collagenase. Data are presented as mean values with SD (n=3), **P < 0.005 
compared with control group. (C) Quantitative estimation of the amounts of ROS 
scavenger enzymes, MnSOD,  GPx, and catalase by Western blot analysis using β-actin 
as a loading control. No signals of MnSOD and catalase were detectable in the 
splenocytes. Data are presented as mean values with SD (n=3). 
 
Fig. 3. Phenotypes related to mitochondrial diseases.  
(A) Estimation of the amount of lactate in the blood of 3-month-old B6 male mice (open 
circles) and age-matched male mito-mice13997 (closed circles) before and after glucose 
loading. Data are presented as mean values with SD (n=3), *P < 0.05 compared with 
control group. (B) Histological analysis of the optic nerve (upper panels, cross-section) 
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and the retina (lower panels, horizontal section) after HE staining. NFL, nerve fiber 
layer; GCL, ganglion cell layer; IPL, internal plexiform layer; INL, internal nuclear 
layer; OPL, outer plexiform layer; ONL, outer nuclear layer. Bar, 100 μm (upper 
panels); Bar, 10 μm (lower panels). 
  
Supplementary Fig. 1. Effects of the G13997A mtDNA introduced from tumor cells 
into ESmt13997 cells on their differentiation. 
Left panels, ES cells; right panels, ESmt13997-7 cells possessing the introduced 
G13997A mtDNA. (A) The primary tumor masses formed in nude mice. Bar, 1 cm. (B) 
Histological analysis of the primary tumor masses after HE staining. Panels a, b, c, and 
d correspond to secretory cells, bone cells, striated muscles, and hair follicles, 
respectively. Bar, 100 μm. 
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Table 1
F1 mice
ES clone % G13997A mtDNA % Chimerism % G13997AmtDNA in the tails
No. of F1 mice with G13997A
mtDNA in the tails / No. of F1 mice
ESmt13997-5 55 40 (♀) 0 0 / 35
40 (♀) 0 0 / 41
50 (♀) 21 0 / 46
50 (♀) 0 0 / 40
50 (♀) 11 0 / 58
50 (♀) 15 0 / 38
80 (♀) 0 0 / 63
80 (♀) 26 7a  / 23
20 (♂) 0
20 (♂) 0
20 (♂) 0
20 (♂) 0
20 (♂) 0
30 (♂) 0
30 (♂) 19
80 (♂) 23
ESmt13997-7 85 5 (♀) 0 0 / 61
40 (♀) 13 0 / 55
90 (♀) 43 0 / 12
5 (♂) 0
5 (♂) 1
10 (♂) 0
20 (♂) 6
30 (♂) 4
ES cells F0 mice
Generation of F0 chimeric mice and their F1 progeny carrying the G13997A mtDNA in tails
a  Seven out of 23 F1 mice possessed homoplasmic G13997A mtDNA in their tails. Two were females and five
were males. We used these two F1 females for breeding, and obtained F2 mito-mice13997. All F2 mito-mice13997
possessed homoplasmic G13997A mtDNA in their tails. The number of F3 pups and their body weight were
comparable to those of B6 mice.
BB8
2m
tA
11
G13997A 114 bp
Wild type 147 bp
F1 mouse tissues 
 TeSkKiLiHeBrB8
2m
tB
6
Afl II digestion
B8
2m
tA
11
F3 mouse tissues
 TeSkKiLiHeBrB8
2m
tB
6
C
G13997A 114 bp
Wild type 147 bp
Afl II digestion
G13997A 114 bp
Wild type 147 bp
ES
ESmt13997 clones
1 2 3 4 5 6 7
7 54 32 55 8549320100% G13997A mtDNA
Afl II digestion
A
B8
2m
tA
11
Fig. 1.
  0
 20
 40
 60
 80
100
120
I +
 II
I a
ct
iv
ity
 (%
)
A
* **
H
2O
2 l
ev
el
s 
(%
)
0
50
100
150
200
*
C
MnSOD GPx
0
50
100
150
P
ro
te
in
 c
on
te
nt
 （
%
）
0
50
100
150
  0
 20
 40
 60
 80
100
120
140
0
20
40
60
80
100
120
140
Catalase
0
50
100
150
B
B8
2m
tB
6
B8
2m
tA
11
1
10
100
1000
10000
II 
+ 
III
 a
ct
iv
ity
 (%
)
IV
 a
ct
iv
ity
 (%
)
B8
2m
tB
6
B8
2m
tA
11
* *
 Brain Kidney Muscle
 B6 Mit  B6 Mit B6 Mit
 Brain Kidney Muscle
 B6 Mit  B6 Mit B6 Mit
 Brain Kidney Muscle
 B6 Mit  B6 Mit B6 Mit
 Liver Spleno
cyte
 B6 Mit  B6 Mit
 Liver Spleno
cyte
 B6 Mit  B6 Mit
 Liver
 B6 Mit
 Liver
 B6 Mit
Fig. 2.
BTime after glucose loading (min)
Bl
oo
d
la
ct
at
e
le
ve
l(
m
m
ol
/l)
0
1
2
3
4
5
6
7
8
9
0 20 40 60 120
*
*
*
●●
●
●
●
● ●
●●●
A
Retina
Optic
nerve
B6 mice mito-mice13997
GCL
NFL
IPL
INL
OPL
ONL
●
●
mito-mice13997
B6 mice
Fig. 3.
Supplementary Table 1
Nuclear donors × mtDNA donors
 Nuclear donors 
 R6G-ESa HAT resistant      without mtDNA
 mtDNA donors 
 B82mtA11b HAT sensitive      G13997A
 Trans-mitochondrial ES cells
 ESmt13997 HAT resistant      G13997A en B82mtA11c × R6G-ES  HATd
 
c  en represents enucleation to obtain cytoplasts without nuclei.
d  To obtain ES cells carrying the G13997A mtDNA (ESmt13997 cells), ES cells were pretreated with R6G to eliminate their
mitochondria and mtDNA, and the resultant R6G-ES cells were fused with enucleated B82mtA11 cells. The fusion mixtures were
cultivated in HAT selection medium to exclude unenucleated B82mtA11 cells. Unfused R6G-ES cells cannot survive due to the
absence of mtDNA and mitochondria.
b  The nuclear DNA is derived from B82 cells that are resistant to BrdU and sensitive to HAT, and mtDNA is derived from highly
metastatic Lewis lung carcinoma A11 cells possessing the G13997A mtDNA.
a  ES cells pretreated with R6G to exclude endogenous mitochondria and mtDNA.
Cell lines
Genetic characteristics of the nuclear donors, mtDNA donors , and resultant trans-mitochondrial ES cells (ESmt13997)
Fusion combination
mtDNA genotypesNuclear genotypes Selection
ESmt13997 - 7ES
A
B
b
c
d
a
Supplementary Fig. 1.
